The overall objective of this proposal is to understand thoroughly the mechanisms by which dual-specificity protein tyrosine phosphatases (DS-PTPs) inactivate the MAP kinases ERK1 and ERK2. Although, the pathways leading to ERK activation have been well described, down-regulating mechanisms involving protein phosphatases remain largely unknown. Recently, two DS-PTPs (VHR and MKP) have been described as specific but distinct ERK phosphatases. VHR is a single domain, tyrosine-specific and nuclear ERK phosphatase. In contrast, MKP3 is a two-domain, dual-specific and cytoplasmic ERK phosphatase. In this proposal, cellular and biochemical approaches will be utilized to explore the diverse mechanisms by which these DS-PTPs down-regulate the ERK signaling pathway.
Specific aim 1 will be explored in detail and the cellular function of VHR in the ERK signaling pathway. The molecular mechanisms of ERK dephosphorylation by MKP3 and VHR will be determined in Specific aim 2.
Specific aim 3 will focus on identifying the physical basis for the dramatic activation of phosphatase activity when MKP3 binds unphosphorylated ERK.
In Specific aim 4, protein co-crystallizations will be initiated for future X-ray structural determinations of the complexes between VHR/ERK and MKP3/ERK. The investigation outlined in this proposal is a logical mix of physiological function and molecular mechanism. The unique characteristics of VHR and MKP3 offer a tremendous opportunity to understand the cellular mechanisms that down-regulate the ERK pathway.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM059785-06
Application #
6815370
Study Section
Biochemistry Study Section (BIO)
Program Officer
Jones, Warren
Project Start
1999-08-01
Project End
2005-07-31
Budget Start
2003-08-09
Budget End
2005-07-31
Support Year
6
Fiscal Year
2003
Total Cost
$193,354
Indirect Cost
Name
University of Wisconsin Madison
Department
Biochemistry
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Qian, Shuiming; Lv, Xinchen; Scheid, Ray N et al. (2018) Dual recognition of H3K4me3 and H3K27me3 by a plant histone reader SHL. Nat Commun 9:2425
Kuznetsov, Vyacheslav I; Haws, Spencer A; Fox, Catherine A et al. (2018) General method for rapid purification of native chromatin fragments. J Biol Chem 293:12271-12282
Krautkramer, Kimberly A; Dhillon, Rashpal S; Denu, John M et al. (2017) Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin. Transl Res 189:30-50
Wang, Xiaoshi; Yuan, Zuo-Fei; Fan, Jing et al. (2016) A Novel Quantitative Mass Spectrometry Platform for Determining Protein O-GlcNAcylation Dynamics. Mol Cell Proteomics 15:2462-75
Krautkramer, Kimberly A; Kreznar, Julia H; Romano, Kymberleigh A et al. (2016) Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues. Mol Cell 64:982-992
Krautkramer, Kimberly A; Reiter, Lukas; Denu, John M et al. (2015) Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry. J Proteome Res 14:3252-62
Fan, Jing; Krautkramer, Kimberly A; Feldman, Jessica L et al. (2015) Metabolic regulation of histone post-translational modifications. ACS Chem Biol 10:95-108
Zhou, Xia; Fan, Lucy X; Sweeney Jr, William E et al. (2013) Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest 123:3084-98
Oliver, Samuel S; Musselman, Catherine A; Srinivasan, Rajini et al. (2012) Multivalent recognition of histone tails by the PHD fingers of CHD5. Biochemistry 51:6534-44
Wagner, Elise K; Albaugh, Brittany N; Denu, John M (2012) High-throughput strategy to identify inhibitors of histone-binding domains. Methods Enzymol 512:161-85

Showing the most recent 10 out of 50 publications